- Home
- SVA vs MIR Comparison
SVA vs MIR Comparison
Compare SVA & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- MIR
- Stock Information
- Founded
- SVA N/A
- MIR 2005
- Country
- SVA
- MIR United States
- Employees
- SVA 3261
- MIR N/A
- Industry
- SVA
- MIR Industrial Machinery/Components
- Sector
- SVA
- MIR Technology
- Exchange
- SVA NYSE
- MIR Nasdaq
- Market Cap
- SVA N/A
- MIR 5.0B
- IPO Year
- SVA N/A
- MIR N/A
- Fundamental
- Price
- SVA $6.47
- MIR $20.42
- Analyst Decision
- SVA
- MIR Strong Buy
- Analyst Count
- SVA 0
- MIR 4
- Target Price
- SVA N/A
- MIR $18.75
- AVG Volume (30 Days)
- SVA N/A
- MIR 3.8M
- Earning Date
- SVA N/A
- MIR 07-31-2025
- Dividend Yield
- SVA N/A
- MIR N/A
- EPS Growth
- SVA N/A
- MIR N/A
- EPS
- SVA N/A
- MIR N/A
- Revenue
- SVA N/A
- MIR $870,200,000.00
- Revenue This Year
- SVA N/A
- MIR $6.45
- Revenue Next Year
- SVA N/A
- MIR $7.51
- P/E Ratio
- SVA N/A
- MIR N/A
- Revenue Growth
- SVA N/A
- MIR 7.25
- 52 Week Low
- SVA N/A
- MIR $9.11
- 52 Week High
- SVA N/A
- MIR $22.21
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- MIR 54.16
- Support Level
- SVA N/A
- MIR $20.14
- Resistance Level
- SVA N/A
- MIR $20.98
- Average True Range (ATR)
- SVA 0.00
- MIR 0.72
- MACD
- SVA 0.00
- MIR -0.18
- Stochastic Oscillator
- SVA 0.00
- MIR 37.41
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.